1. 2018
  2. AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

    Gillissen, M. A., Kedde, M., Jong, G. D., Moiset, G., Yasuda, E., Levie, S. E., Bakker, A. Q., Claassen, Y. B., Wagner, K., Böhne, M., Hensbergen, P. J., Speijer, D., van Helden, P. M., Beaumont, T., Spits, H. & Hazenberg, M. D., 2018, In: Blood. 131, 1, p. 131-143

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Mesenchymal stromal cells stimulate the proliferation and IL-22 production of group 3 innate lymphoid cells

    van Hoeven, V., Munneke, J. M., Cornelissen, A. S., Omar, S. Z., Spruit, M. J., Kleijer, M., Bernink, J. H., Blom, B., Voermans, C. & Hazenberg, M. D., 2018, In: Journal of immunology (Baltimore, Md.. 201, 4, p. 1165-1173

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Risico op trombose bij reactieve trombocytose

    Hengeveld, P. J., Hazenberg, M. D., Biezeveld, M. H. & Raphael, M. F., 2018, In: Nederlands tijdschrift voor geneeskunde. 162, 41, D2697.

    Research output: Contribution to journalArticleProfessional

  5. Stool can soften GVHD

    Hazenberg, M. D., 2018, In: Blood. 132, 23, p. 2429-2430 2 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2017
  7. Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients

    Willemse, S. B., Bezuur, D. L., Blom, P., Kneppers, E., Verheij, J., Zaaijer, H. L. & Hazenberg, M. D., 2017, In: Bone marrow transplantation. 52, 4, p. 622-624

    Research output: Contribution to journalComment/Letter to the editorAcademic

  8. Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice

    Gillissen, M. A., de Jong, G., Kedde, M., Yasuda, E., Levie, S. E., Moiset, G., Hensbergen, P. J., Bakker, A. Q., Wagner, K., Villaudy, J., van Helden, P. M., Spits, H. & Hazenberg, M. D., 2017, In: Blood advances. 1, 19, p. 1551-1564

    Research output: Contribution to journalArticleAcademicpeer-review

  9. 2016
  10. AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses

    Gillissen, M. A., de Jong, G., Levie, S. E., Yasuda, E., Bakker, A. Q., Evers, L. M., Pals, S. T., Huisman, C., van Helden, P. M., Spits, H. & Hazenberg, M. D., 2016, In: Bone marrow transplantation. 51, 9, p. 1245-1248

    Research output: Contribution to journalComment/Letter to the editorAcademic

  11. Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia

    de Weerdt, I., van Hoeven, V., Munneke, J. M., Endstra, S., Hofland, T., Hazenberg, M. D. & Kater, A. P., 2016, In: Haematologica. 101, 11, p. e461-e464

    Research output: Contribution to journalComment/Letter to the editorAcademic

  12. Reconciling Longitudinal Naive T-Cell and TREC Dynamics during HIV-1 Infection

    Drylewicz, J., Vrisekoop, N., Mugwagwa, T., de Boer, A. B., Otto, S. A., Hazenberg, M. D., Tesselaar, K., de Boer, R. J. & Borghans, J. A. M., 2016, In: PLoS ONE. 11, 3, p. e0152513

    Research output: Contribution to journalArticleAcademicpeer-review

  13. T-cells fighting B-cell lymphoproliferative malignancies: the emerging field of CD19 CAR T-cell therapy

    Heijink, D. M., Kater, A. P., Hazenberg, M. D., Hagenbeek, A. & Kersten, M. J., 2016, In: Netherlands journal of medicine. 74, 4, p. 147-151

    Research output: Contribution to journalReview articleAcademicpeer-review

ID: 59529